GENEVA, Aug. 21 -- HEFEI TG IMMUNOPHARMA CO., LTD. filed a patent application (CN2024/131726) for “BLOCKING CD40 ANTIBODY AND USE THEREOF”. With publication no. WO/2025/124055, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....